These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26042340)

  • 1. Development of novel CXC chemokine receptor 7 (CXCR7) ligands: selectivity switch from CXCR4 antagonists with a cyclic pentapeptide scaffold.
    Oishi S; Kuroyanagi T; Kubo T; Montpas N; Yoshikawa Y; Misu R; Kobayashi Y; Ohno H; Heveker N; Furuya T; Fujii N
    J Med Chem; 2015 Jul; 58(13):5218-25. PubMed ID: 26042340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationship Study of Cyclic Pentapeptide Ligands for Atypical Chemokine Receptor 3 (ACKR3).
    Sekiguchi H; Kuroyanagi T; Rhainds D; Kobayashi K; Kobayashi Y; Ohno H; Heveker N; Akaji K; Fujii N; Oishi S
    J Med Chem; 2018 Apr; 61(8):3745-3751. PubMed ID: 29608300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
    Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
    J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging ligand-dependent activation of CXCR7.
    Luker KE; Gupta M; Steele JM; Foerster BR; Luker GD
    Neoplasia; 2009 Oct; 11(10):1022-35. PubMed ID: 19794961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7.
    Ehrlich A; Ray P; Luker KE; Lolis EJ; Luker GD
    Biochem Pharmacol; 2013 Nov; 86(9):1263-71. PubMed ID: 23973527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.
    Thiele S; Mungalpara J; Steen A; Rosenkilde MM; Våbenø J
    Br J Pharmacol; 2014 Dec; 171(23):5313-29. PubMed ID: 25039237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein‑mediated EGFR transactivation is a common mechanism through which the CXCL12 receptors, CXCR4 and CXCR7, control human cancer cell migration.
    Zieger-Naumann K; Kuhl F; Engele J
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38099418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.
    Luker KE; Steele JM; Mihalko LA; Ray P; Luker GD
    Oncogene; 2010 Aug; 29(32):4599-610. PubMed ID: 20531309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.
    Coggins NL; Trakimas D; Chang SL; Ehrlich A; Ray P; Luker KE; Linderman JJ; Luker GD
    PLoS One; 2014; 9(6):e98328. PubMed ID: 24896823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres.
    Kobayashi K; Oishi S; Hayashi R; Tomita K; Kubo T; Tanahara N; Ohno H; Yoshikawa Y; Furuya T; Hoshino M; Fujii N
    J Med Chem; 2012 Mar; 55(6):2746-57. PubMed ID: 22352868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presumed atypical chemokine receptor CXCR7 signals through G(i/o) proteins in primary rodent astrocytes and human glioma cells.
    Odemis V; Lipfert J; Kraft R; Hajek P; Abraham G; Hattermann K; Mentlein R; Engele J
    Glia; 2012 Mar; 60(3):372-81. PubMed ID: 22083878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4).
    Zachariassen ZG; Thiele S; Berg EA; Rasmussen P; Fossen T; Rosenkilde MM; Våbenø J; Haug BE
    Bioorg Med Chem; 2014 Sep; 22(17):4759-69. PubMed ID: 25082513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
    Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
    J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
    Hunger C; Ödemis V; Engele J
    Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
    Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
    J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
    Costantini S; Raucci R; De Vero T; Castello G; Colonna G
    Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR7/CXCR4 heterodimer constitutively recruits beta-arrestin to enhance cell migration.
    Décaillot FM; Kazmi MA; Lin Y; Ray-Saha S; Sakmar TP; Sachdev P
    J Biol Chem; 2011 Sep; 286(37):32188-97. PubMed ID: 21730065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.